Emergence of the Next Generation of Anti-Psychotics

Time: 2:05 pm
day: Day Two


• Diving into KarXT, a novel medicine for treating psychosis
• Preferentially targeting and stimulating muscarinic receptors in the central nervous system and leaving those in the peripheral tissues unaffected
• Sharing clinical data and outlining the steps involved in initiating the Phase III trial